SUPPLY ISSUE Neostigmine metisulfate with glycopyrronium bromide injection Pharmacode 2444097
MAXhealth have advised of a supply issue with the incumbent brand (Martindale) of this product.
MAXhealth will temporarily be supplying a UK approved Glycopyrronium 500mcg & Neostigmine 2.5 mg Injection 10 x 1 ml from Mercury Pharma to fill an out-of-stock situation with the current supplier.
Despite global shortages of this product MAXhealth have the Mercury Pharma product available from 12 March 2020 until the Martindale product becomes available again. Available from Onelink.
The replacement product of Glycopyrronium 500 mcg & Neostigmine 2.5 mg injection will be in a pack which differs from the NZ approved pack, so this will be supplied under S29. HML price will be maintained at $20.90 excluding GST.
At time of notification no Pharmacode had been advised. This is a PROCURE line, please order accordingly.
Please note as with all Section 29 products we are not able to accept credit returns, so please order with care.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.